Prevention of rejection of transforming growth factor beta-treated rat-to-mouse islet xenografts by monoclonal antibody to tumor necrosis factor.
Carel
J C
JC
Department of Pathology, Washington University School of Medicine, St. Louis, Missouri 63110.
Sheehan
K C
KC
Schreiber
R D
RD
Lacy
P E
PE
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D006084:Graft Rejection; D016381:Islets of Langerhans Transplantation / Q000009:adverse effects*; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D051381:Rats; D011920:Rats, Inbred WF; D016212:Transforming Growth Factor beta / Q000627:therapeutic use*; D014183:Transplantation, Heterologous; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology* / Q000502:physiology
D000911:Antibodies, Monoclonal; D016212:Transforming Growth Factor beta; D014409:Tumor Necrosis Factor-alpha